EnteroBiotix Company

Microbiome modulating drugs, preventative treatment. Mission is to harness the therapeutic potential of diverse and intact donor-derived microbial communities to redefine the way we treat disease and improve health and wellbeing.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 2017
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: £2.5M
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
Register and Claim Ownership